SecBot SecBot
SECBOTREPLAY Home › Report › EWTX

EWTX · Five C-suite insiders at Edgewise Therapeutics sold a total of ~$401K…

Edgewise Therapeutics, Inc. · CLUSTER filed Aug 14, 2026 at 16:54 ET

At the news

NEUTRALIMPACT 4/10

CLUSTER filed Aug 14, 2026 at 16:54 ET

Five C-suite insiders at Edgewise Therapeutics sold a total of ~$401K in open-market shares on August 12, 2026, following the company's Q2 earnings miss and the transformative sevasemten sale to Servier. The sales are small relative to the $4.8B market cap (0.008%), but the cluster of all top executives selling on the same day after a major corporate pivot warrants attention. The non-cash grants and derivative exercises on the same date suggest these sales are likely liquidity-driven to cover tax obligations from vesting, not a bearish signal on the company's cardiovascular-focused future.

  • Five C-suite insiders (CEO, CFO, CMO, CSO, CBO) sold shares on August 12, 2026
  • Total open-market sales: ~$401K, or 0.008% of $4.8B market cap
  • Sales occurred 6 days after Q2 2026 earnings miss ($0.53 loss vs $0.47 consensus) and the $1.55B sevasemten sale to Servier
  • All insiders also received large non-cash stock grants and exercised derivatives on the same date, indicating tax-withholding sales

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access